Annual SGA
$110.82 M
+$29.22 M+35.81%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual SGA is $110.82 million, with the most recent change of +$29.22 million (+35.81%) on December 31, 2023.
- During the last 3 years, RXRX annual SGA has risen by +$85.56 million (+338.76%).
- RXRX annual SGA is now at all-time high.
Performance
RXRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$37.76 M
+$5.92 M+18.61%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly SGA is $37.76 million, with the most recent change of +$5.92 million (+18.61%) on September 30, 2024.
- Over the past year, RXRX quarterly SGA has increased by +$6.35 million (+20.21%).
- RXRX quarterly SGA is now at all-time high.
Performance
RXRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.44 B
-$377.75 M-9.31%
September 30, 2024
Summary
- As of February 7, 2025, RXRX TTM SGA is -$4.44 billion, with the most recent change of -$377.75 million (-9.31%) on September 30, 2024.
- Over the past year, RXRX TTM SGA has dropped by -$4.55 billion (-3816.25%).
- RXRX TTM SGA is now -1976.55% below its all-time high of -$213.60 million.
Performance
RXRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RXRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.8% | +20.2% | -3816.3% |
| 3 y3 years | +338.8% | +90.3% | -5535.8% |
| 5 y5 years | +484.8% | +90.3% | -5535.8% |
RXRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +92.1% | at high | +96.6% | -250.0% | at low |
| 5 y | 5-year | at high | +484.8% | at high | +631.9% | -1976.5% | at low |
| alltime | all time | at high | +484.8% | at high | +631.9% | -1976.5% | at low |
Recursion Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $37.76 M(+18.6%) | $131.46 M(+7.0%) |
| Jun 2024 | - | $31.83 M(+1.4%) | $122.90 M(+3.0%) |
| Mar 2024 | - | $31.41 M(+3.1%) | $119.36 M(+7.7%) |
| Dec 2023 | $110.82 M(+35.8%) | $30.46 M(+4.3%) | $110.82 M(+10.6%) |
| Sep 2023 | - | $29.20 M(+3.2%) | $100.20 M(+10.7%) |
| Jun 2023 | - | $28.29 M(+23.7%) | $90.49 M(+8.5%) |
| Mar 2023 | - | $22.87 M(+15.3%) | $83.40 M(+2.2%) |
| Dec 2022 | $81.60 M | $19.84 M(+1.8%) | $81.60 M(+0.8%) |
| Sep 2022 | - | $19.49 M(-8.1%) | $80.96 M(+4.9%) |
| Jun 2022 | - | $21.20 M(+0.6%) | $77.16 M(+10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $21.07 M(+9.8%) | $69.82 M(+21.0%) |
| Dec 2021 | $57.68 M(+128.4%) | $19.20 M(+22.4%) | $57.68 M(+25.2%) |
| Sep 2021 | - | $15.69 M(+13.3%) | $46.05 M(+23.4%) |
| Jun 2021 | - | $13.85 M(+55.0%) | $37.33 M(+30.4%) |
| Mar 2021 | - | $8.94 M(+18.0%) | $28.63 M(+13.4%) |
| Dec 2020 | $25.26 M(+33.3%) | - | - |
| Dec 2020 | - | $7.57 M(+8.8%) | $25.26 M(+42.8%) |
| Sep 2020 | - | $6.96 M(+35.0%) | $17.68 M(+65.0%) |
| Jun 2020 | - | $5.16 M(-7.2%) | $10.72 M(+92.8%) |
| Mar 2020 | - | $5.56 M | $5.56 M |
| Dec 2019 | $18.95 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual SGA year-on-year change?
- What is Recursion Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly SGA year-on-year change?
- What is Recursion Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM SGA year-on-year change?
What is Recursion Pharmaceuticals annual SGA?
The current annual SGA of RXRX is $110.82 M
What is the all time high annual SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual SGA is $110.82 M
What is Recursion Pharmaceuticals annual SGA year-on-year change?
Over the past year, RXRX annual SGA has changed by +$29.22 M (+35.81%)
What is Recursion Pharmaceuticals quarterly SGA?
The current quarterly SGA of RXRX is $37.76 M
What is the all time high quarterly SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly SGA is $37.76 M
What is Recursion Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, RXRX quarterly SGA has changed by +$6.35 M (+20.21%)
What is Recursion Pharmaceuticals TTM SGA?
The current TTM SGA of RXRX is -$4.44 B
What is the all time high TTM SGA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM SGA is -$213.60 M
What is Recursion Pharmaceuticals TTM SGA year-on-year change?
Over the past year, RXRX TTM SGA has changed by -$4.55 B (-3816.25%)